 Home > Chemicals Industry > Rubber Plastic News > Kasai Bio's hard core patent litigation finally won

Kasai Bio's hard core patent litigation finally won

 Last Update: 2022-08-22
 Source: Internet
 Author: User

Tags

new hpv virus

gold carbon fiber

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On March 24, 2020, Shanghai Kasai Biotechnology Co.
, Ltd.
(hereinafter referred to as "Kasai Bio") received the first round of inquiries from the Shanghai Stock Exchange Science and Technology Innovation Board and completed the reply

One hundred secrets and one sparse open a long ten-year rights protection road

Looking back at the beginning and end of this patent dispute case, the main point of contention between Kasai Biotech and Shandong Hanlin lies in the ownership of 10 long-chain dibasic acid industrialization technology patents

For innovative (technological) enterprises, the right carrier of the technological achievements produced by R&D investment is intellectual property rights, and intellectual property protection is very important for the company's future market benefits

But fortunately, under the ten-year persistence and efforts of Kasai Bio, after the first trial, the final trial and the retrial by the Supreme Court, Kasai won the case, and the ownership of the 10 patents/patent applications involved all belonged to Kasai, there is no ownership dispute at present, and the confirmation of ownership has also strengthened the intellectual property protection barriers of Kasai Bio in the core technology of long-chain dibasic acid

In-depth research in the field of biotechnology reflects the first-class level of scientific research ingenuity

Kasai Bio is a high-tech enterprise engaged in the research and development, production and sales of new bio-based materials based on synthetic biology and other disciplines, using bio-manufacturing technology

It is understood that long-chain dibasic acids have been biotransformed in biological laboratories as early as more than 20 years ago, but due to technical bottlenecks, low output rates, high costs and substandard product quality, industrialization cannot be achieved

In addition, it is worth mentioning that the bio-based materials that Kasai Bio are mainly targeting have not only commercial value, but also strong scientific value and social significance

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.